Komen has sustained a strong commitment to supporting research that will identify and deliver cures for breast cancer. This commitment has resulted in important progress that has contributed to every major advance in breast cancer over the past 25 years. With increasing investments over time, Komen is now the largest non-government funder of breast cancer research.
 

Our research focus has evolved over the years. In the beginning we focused on understanding the basic biology of breast cancer. As we learn more about the factors that make cancer cells grow and spread, we are able to invest more in the translation of this knowledge into treatment, early detection and prevention.

Komen's Scientific Advisory Board guides our research focus, identifying the most promising areas of research and the critical questions that need to be answered. The Komen Scholars, through a highly structured peer review process, help identify the most promising projects for funding.  With the guidance of these experts, Komen invests every research dollar as carefully and conscientiously as possible.

The following research highlights provide additional information:  

Research Fast Facts 

BRCA Gene Mutations 

Complimentary and Alternative Therapies 

Early Detection 

HER2 Breast Cancer 

Metastases 

Promise Grant Summaries

Promise Grant Snapshot 

Research Hall of Fame

Dr. Lewis Chodosh 

Dr. Nancy Davidson 

Dr. Patricia Ganz 

Dr. V. Craig Jordan 

Dr. C. Kent Osborne 

Dr. Robert A. Weinberg 

Chronicles of Hope

Ute Bankamp      (en Español)  

Bonnie Olson 

Terri Swain 

Nicole Vazquez      (en Español) 

Rebecca West      (en Español)